However, none of CD3+, CD4+, CD8+ TILs had independent prognostic value (Gao et al., 2007), suggesting that a further illustration of HCC-infiltrating T cells and identification of biomarkers in HCC immune responses are needed. The gene discussed is CD4; the disease is hepatocellular carcinoma.